norfluoxetine has been researched along with MS (Multiple Sclerosis) in 1 studies
norfluoxetine: metabolite of fluoxetine; RN given refers to parent cpd without isomeric designation
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Otton, SV | 1 |
| Wu, D | 1 |
| Joffe, RT | 1 |
| Cheung, SW | 1 |
| Sellers, EM | 1 |
1 other study available for norfluoxetine and MS (Multiple Sclerosis)
| Article | Year |
|---|---|
Inhibition by fluoxetine of cytochrome P450 2D6 activity.
Topics: Adult; Cytochrome P-450 CYP2D6; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; | 1993 |